Posters

Refractive outcomes after femtosecond laser-assisted cataract surgery in eyes with anterior chamber phakic intraocular lenses

Poster Details

First Author: G.Steinwender AUSTRIA

Co Author(s): M. Shajari   T. Kohnen                 

Abstract Details

Purpose:

To report the efficacy, predictability, and safety of femtosecond laser-assisted cataract surgery (FLACS) in eyes with anterior chamber phakic intraocular lenses (pIOL).

Setting:

Department of Ophthalmology, Goethe-University, Frankfurt, Germany

Methods:

This retrospective case series included eyes with previous implantation of an angle-supported and iris-fixated pIOL for the correction of myopia which underwent a combined procedure of pIOL explantation and FLACS with in-the-bag implantation of a posterior chamber intraocular lens (IOL). Postoperative corrected distance visual acuity (CDVA), predictability of refractive outcome, and occurrence of intra- and postoperative complications were analyzed.

Results:

Ten eyes of 7 patients with significant cataract were included, thereof 5 eyes with an angle-supported foldable hydrophobic pIOL, 4 eyes with an angle-supported polymethylmethacrylate (PMMA) pIOL, and 1 eye with an iris-fixated PMMA pIOL. Mean follow-up after FLACS was 8.4 ± 5.8 (SD) months. Mean interval between pIOL implantation and FLACS was 11.9 ± 4.0 years. After the combined procedure of pIOL explantation and FLACS mean manifest refractive spherical equivalent (MRSE) was -0.12 ± 0.51 D, and MRSE was within ± 0.75 D of target refraction in all eyes. Four eyes received a toric posterior chamber IOL after phacoemulsification. Mean preoperative CDVA of 0.40 ± 0.24 logMAR improved significantly to 0.23 ± 0.12 logMAR postoperatively (P=0.027). No intraoperative or postoperative complications occurred.

Conclusions:

The results in our series showed that FLACS in eyes with previous implantation of both rigid and foldable anterior chamber pIOLs offers good refractive outcomes with a high level of predictability and safety.

Financial Disclosure:

... receives consulting fees, retainer, or contract payments from a company producing, developing or supplying the product or procedure presented, ... research is funded, fully or partially, by a company producing, developing or supplying the product or procedure presented